Sökning: WFRF:(Schmitt Anneli 1971) >
Radiation therapy o...
-
Schmitt, Anneli,1971Gothenburg University,Göteborgs universitet,Institutionen för särskilda specialiteter, Avdelningen för radiofysik,Institute of Selected Clinical Sciences, Department of Radiation Physics
(författare)
Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model
- Artikel/kapitelEngelska2004
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:gup.ub.gu.se/46989
-
https://gup.ub.gu.se/publication/46989URI
Kompletterande språkuppgifter
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Small cell lung cancer (SCLC) is a tumor of neuroendocrine (NE) origin with very low survival rate. Somatostatin receptor scintigraphy using 111In-DTPA-octreotide (DTPA is diethylenetriaminepentaacetic acid) is a well-established method for the visualization of somatostatin receptor-expressing NE tumors. Recently, new combinations of radionuclides and somatostatin analogs have been investigated for therapeutic purposes. In this study, the somatostatin analog DOTA-Tyr3-octreotate (DOTA is 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid), labeled with the medium-energy electron emitter 177Lu (maximal electron energy = 498 keV, half-life = 6.6 d), was used for radiation therapy of human SCLC in an animal model. METHODS: Nude mice, bearing tumors from the human SCLC cell line NCI-H69, were injected intravenously with 177Lu-DOTA-Tyr3-octreotate. Groups of animals (n = 5 or 6) were injected with 45-, 60-, and 120-MBq fractions and two 45-MBq fractions 48 h apart. Furthermore, 1 control group was treated with unlabeled DOTA-Tyr3-octreotate and another control group was not treated. RESULTS: In both control groups, the tumor volumes were increased 2-fold in approximately 5 d. Treatment with 177Lu-DOTA-Tyr3-octreotate resulted in marked tumor regression with statistically significant tumor volume reduction after 1 wk (P < 0.001). The tumor growth delay time was dependent on the amount of injected activity for the groups with single injections, 26 d for 60 MBq and 40 d for 120 MBq. The best therapeutic effect was obtained in mice injected with 2 fractions of 45 MBq. The relative tumor volume after 1 mo was 0.004 +/- 0.004. CONCLUSION: Radiation therapy with 177Lu-DOTA-Tyr3-octreotate on SCLC-bearing mice was successful. Since the experiments were performed on a human SCLC cell line xenografted to nude mice, the results may be clinically relevant and treatment with 177Lu-DOTA-Tyr3-octreotate could be a treatment alternative in this tumor disease that normally has a dismal prognosis.
Ämnesord och genrebeteckningar
-
Animals
-
Carcinoma
-
Small Cell/*metabolism/*radiotherapy
-
Disease Models
-
Animal
-
Injections
-
Intravenous
-
Lung Neoplasms/metabolism/radiotherapy
-
Male
-
Metabolic Clearance Rate
-
Mice
-
Mice
-
Inbred BALB C
-
Mice
-
Nude
-
Organ Specificity
-
dosage/*pharmacokinetics/*therapeutic use
-
Radiopharmaceuticals/administration & dosage/pharmacokinetics/therapeutic
-
use
-
Tissue Distribution
-
Treatment Outcome
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Bernhardt, Peter,1966Gothenburg University,Göteborgs universitet,Institutionen för särskilda specialiteter, Avdelningen för radiofysik,Institute of Selected Clinical Sciences, Department of Radiation Physics(Swepub:gu)xbernp
(författare)
-
Nilsson, Ola,1957Gothenburg University,Göteborgs universitet,Institutionen för laboratoriemedicin , Avdelningen för patologi,Institute of Laboratory Medicine, Dept of Pathology(Swepub:gu)xnilol
(författare)
-
Ahlman, Håkan,1947Gothenburg University,Göteborgs universitet,Institutionen för de kirurgiska disciplinerna, Avdelningen för kirurgi,Institute of Surgical Sciences, Department of Surgery(Swepub:gu)xahlha
(författare)
-
Kölby, Lars,1963Gothenburg University,Göteborgs universitet,Institutionen för de kirurgiska disciplinerna, Avdelningen för kirurgi,Institute of Surgical Sciences, Department of Surgery(Swepub:gu)xkolbl
(författare)
-
Maecke, H. R.
(författare)
-
Forssell-Aronsson, Eva,1961Gothenburg University,Göteborgs universitet,Institutionen för särskilda specialiteter, Avdelningen för radiofysik,Institute of Selected Clinical Sciences, Department of Radiation Physics(Swepub:gu)xforev
(författare)
-
Göteborgs universitetInstitutionen för särskilda specialiteter, Avdelningen för radiofysik
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of nuclear medicine45:9, s. 1542-80161-5505
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Schmitt, Anneli, ...
-
Bernhardt, Peter ...
-
Nilsson, Ola, 19 ...
-
Ahlman, Håkan, 1 ...
-
Kölby, Lars, 196 ...
-
Maecke, H. R.
-
visa fler...
-
Forssell-Aronsso ...
-
visa färre...
- Artiklar i publikationen
-
Journal of nucle ...
- Av lärosätet
-
Göteborgs universitet